Follow Parkinson's News Today on Feedspot

Continue with Google
Continue with Facebook

Likely cognitive decline, dementia risk, and the severity of motor symptoms in Parkinson’s disease might be tracked by measuring the ..read more
Scientists have developed a new cellular model that can help reconstruct the entire process of Lewy body formation — a key event that ..read more
When my kids were younger and still in school, I volunteered to be a driver for most of their field trips. One of the most memorable ..read more
Annovis Bio’s lead investigative therapy ANVS401 (also known as Posiphen) targeting protein buildup in the brain has been granted a U.S ..read more
Aggregates of the Parkinson’s disease-associated protein alpha-synuclein can spread from the gut to the brain in mice, but this process ..read more
“Oh, poor me. I have lost so much,” I moan, hanging my head down and shuffling my feet. My partner looks up from her book. “Did you ..read more
Scientists have uncovered a new therapeutic molecule, called BT13, that can get to the brain to boost dopamine levels — the brain ..read more
Researchers characterized the structure and interactions of proteins connected to the leucine-rich repeat kinase 2 (LRRK2) gene, the most ..read more
Long-term treatment with Gocovri (amantadine) extended-release capsules was safe and led to sustained reductions in dyskinesia — ..read more
RTB101, an investigational therapy being developed to treat Parkinson’s disease, is well-tolerated, can cross the blood-brain barrier, ..read more

Separate tags by commas
To access this feature, please upgrade your account.
Start your free month
Free Preview